MedTrace Logo

NovaTears® Eye Drops Observational Study NT-003

NCT02356328 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 25

Last updated 2016-03-09

No results posted yet for this study

Summary

This observational study is intended to collect outcome data from a cohort of 30 patients suffering from dry eye disease due to chronic ocular Graft-versus-Host Disease (GvHD) who are treated with the medical device NovaTears® eye drops for a duration of 11 to 13 weeks.

Conditions

  • Dry Eye Syndromes

Interventions

DEVICE

NovaTears® Eye Drops

Topical eye drops for lubrication of the ocular surface

Sponsors & Collaborators

  • Novaliq GmbH

    lead INDUSTRY

Principal Investigators

  • Novaliq GmbH · Novaliq GmbH

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2016-01-31
Completion
2016-01-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02356328 on ClinicalTrials.gov